Back
Smith & Nephew PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
34
SNN
Smith & Nephew PLC
Last Price:
25.28
Seasonality Move:
8.72%
Sell
20
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.66
Seasonality Move:
50.57%
Sell
34
Smith & Nephew PLC (SNN)
is a Sell
Is Smith & Nephew PLC a Buy, Sell or Hold?
- The current Smith & Nephew PLC [SNN] share price is $25.04. The Score for SNN is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- SNN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.64. The Score for ADAP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
SNN Stock Price Chart
What is Smith & Nephew PLC's stock price today?
-
The Smith & Nephew PLC share price today is $25.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SNN is experiencing slight selling pressure.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.64
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.
SNN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.96 | Sell |
| Relative Strength Index (14 RSI): | 36.19 | Sell |
| Chaikin Money Flow: | -55406 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.43 - 28.49) | Sell |
| Bollinger Bands (100): | (26.72 - 31) | Sell |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 36.24 | Sell |
| Chaikin Money Flow: | -608296 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.66 - 0.82) | Sell |
| Bollinger Bands (100): | (0.81 - 1.21) | Sell |
SNN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25 | Buy |
| 20-day SMA: | 25.72 | Sell |
| 50-day SMA: | 28.28 | Sell |
| 200-day SMA: | 27.33 | Sell |
| 8-day EMA: | 25.15 | Sell |
| 20-day EMA: | 25.86 | Sell |
| 50-day EMA: | 27.37 | Sell |
| 200-day EMA: | 27.69 | Sell |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.66 | Sell |
| 20-day SMA: | 0.73 | Sell |
| 50-day SMA: | 0.85 | Sell |
| 200-day SMA: | 1.12 | Sell |
| 8-day EMA: | 0.67 | Sell |
| 20-day EMA: | 0.73 | Sell |
| 50-day EMA: | 0.83 | Sell |
| 200-day EMA: | 1 | Sell |
Smith & Nephew PLC Earnings Growth & SNN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.28 per share, and an increase next year of $0.30 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.
Smith & Nephew PLC Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||